0001209191-22-032515.txt : 20220527
0001209191-22-032515.hdr.sgml : 20220527
20220527161606
ACCESSION NUMBER: 0001209191-22-032515
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220525
FILED AS OF DATE: 20220527
DATE AS OF CHANGE: 20220527
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Siegel Jolie
CENTRAL INDEX KEY: 0001768223
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39567
FILM NUMBER: 22977695
MAIL ADDRESS:
STREET 1: C/O NEON THERAPEUTICS, INC.
STREET 2: 40 ERIE ST., SUITE 110
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: C4 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662579
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 475617627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: (617) 231-0700
MAIL ADDRESS:
STREET 1: 490 ARSENAL WAY
STREET 2: SUITE 200
CITY: WATERTOWN
STATE: MA
ZIP: 02472
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-25
0
0001662579
C4 Therapeutics, Inc.
CCCC
0001768223
Siegel Jolie
C/O C4 THERAPEUTICS, INC.
490 ARSENAL WAY #200
WATERTOWN
MA
02472
0
1
0
0
Chief Legal Officer
Common Stock
2022-05-25
4
M
0
3750
A
3750
D
Performance Restricted Stock Units
2022-05-25
4
M
0
3750
0.00
D
2025-02-28
Common Stock
3750
22500
D
Each performance restricted stock unit ("PRSU") represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 4,500 PRSUs shall vest upon satisfaction of three escalating share price vesting milestones, and the remaining PRSUs vest upon satisfaction of certain discovery and clinical milestones.
/s/ Jolie M. Siegel
2022-05-27